Eric E. Schadt founded Sema4 Holdings Corp. and Mount Sinai Genomics, Inc. Currently, Dr. Schadt holds the position of Chief Executive Officer & Director at Sema4 Holdings Corp. and Chief Executive Officer & Director at Mount Sinai Genomics, Inc. (a subsidiary of Sema4 Holdings Corp.).
He is also on the board of Station X, Inc., Sage Bionetworks and 4Youandme and Dean-Precision Medicine at Icah School of Medicine at Mount Sinai.
Eric E. Schadt previously was Chief Scientific Officer of Pacific Biosciences of California, Inc., Executive Scientific Director at Rosetta Inpharmatics LLC and Senior Research Scientist at Roche Bioscience.
He received an undergraduate degree from California Polytechnic State University (San Luis Obispo), a doctorate from the University of California, Los Angeles and a graduate degree from the University of California, Davis.